[165 Pages Report] The global urinary catheters market size is projected to reach USD 2.6 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 5.5% during the forecast period. The growing prevalence of urinary incontinence, an increasing number of surgical procedures across the globe, high incidence of prostate cancer, and the favorable reimbursement scenario are the major factors driving the growth of the urinary catheters market. However, the availability of alternative treatment options for urinary incontinence may restrict market growth to a certain extent.

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact on the urinary catheters market

COVID-19 has resulted in significant disruptions to businesses and economic activities globally and is expected to have a short-term negative impact on the urinary catheters market. Urinary catheters used for surgical applications are expected to be impacted to some extent due to the temporary postponement of various elective surgeries, as governments and authorities seek to ensure the availability of resources for COVID-19 patients. In an effort to reduce the strain on the healthcare system, decrease disease transmission, and conserve personal protective equipment (PPE), various governments have provided guidelines on elective surgeries. As of March 18, 2020, the US CMS announced that all elective surgeries, as well as non-essential medical, surgical, and dental procedures, would be delayed. Other areas that are negatively impacted include the supply of products meant for hospitals (including ICUs, emergency rooms, neurological care centers, and trauma patients) due to lockdowns and mobility restrictions in various countries around the globe. However, businesses are likely to revive and resume normalcy once restrictions on elective surgeries and movement are lifted.

Global Urinary Catheters Market Dynamics

DRIVER: Growing prevalence of urinary incontinence

The high prevalence of urinary incontinence is a major factor leading to the increased demand for urinary catheters, globally. Prevalence rates are higher in the elderly population and among nursing home patients. Urinary catheters are used to manage incontinence, which cannot be treated or managed with medicines or surgery. The prevalence of urinary incontinence is expected to grow due to the growing aging population and the increasing incidence of obesity, as these are the two major risk factors for urinary incontinence further.

RESTRAINT: Complications associated catheterization and availability of alternatives

Catheterization is a painful process. The insertion and removal of poorly lubricated catheters can cause friction between the urethral walls and the surface of the device, which is not only painful for the patient but can also, upon regular use, lead to the narrowing of the urethra, bleeding, and infection. Special care is required during catheterization to prevent urinary tract infections (UTIs) or catheter-associated urinary tract infections (CAUTIs). As a result, there are various alternative invasive and non-invasive treatment options in place for the treatment of temporary incontinence. Their availability, given the disadvantages of catheterization, is expected to limit the market for urinary catheters.

OPPORTUNITY: Emerging economies

Emerging economies (such as China, India, South Korea, Brazil, and Mexico) offer significant growth opportunities to major market players. This can be attributed to their low regulatory barriers, improvements in healthcare infrastructure, growing patient population, and rising healthcare expenditure. The regulatory policies in the Asia Pacific are more adaptive and business-friendly than those in developed countries. This, along with the increasing competition in mature markets, has drawn key players in the urinary catheters market to focus on emerging countries. For instance, in April 2018, B. Braun opened five new medical production facilities in Penang, Malaysia, and in 2017, it established a subsidiary in Zambia.

The coated catheters segment will witness the highest growth during the forecast period.

Based on catheter type, the global urinary catheters market is segmented into coated and uncoated catheters. Coated catheters accounted for the largest share of the urinary catheters market in 2019. This segment is also expected to register the highest CAGR during the forecast period. The growth in this market is primarily attributed to the various advantages associated with coated catheters, such as easier, more comfortable insertion, low risk of catheter-associated urinary tract infection, reduced risk of urethral damage, and improved patient satisfaction.

The urinary continence segment dominated the urinary catheters market in 2019.

Based on application, the global urinary catheters market is segmented into urinary incontinence, general surgery, benign prostatic hyperplasia, and other applications. The urinary incontinence segment accounted for the largest share of the urinary catheters market in 2019. This segment is also expected to witness the highest CAGR during the forecast period. The large share and high growth of this segment can primarily be attributed to the increasing incidence of urinary incontinence, the growing geriatric population, and the increasing incidence of obesity.

To know about the assumptions considered for the study, download the pdf brochure

North America was the largest regional market for urinary catheters in 2019.

The urinary catheters market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest regional segment of the overall market, followed by Europe. Factors such as the high prevalence of diseases, growing geriatric population, the availability of advanced interventional products (including urinary catheters), and increasing surgical procedures performed in the region are driving market growth in North America.

Key Market Players

The prominent players operating in this market include B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Coloplast Ltd. (Denmark), ConvaTec Inc. (UK), Becton, Dickinson and Company (US), and Cardinal Health (US).

Scope of the report

Report Metric Details Market size available for years 2018�2025 Base year considered 2019 Forecast period 2020�2025 Forecast units Value (USD) Segments covered Product, type, usage, application, end user, and region Geographies covered North America, Europe, Asia Pacific, and the Rest of the World Companies covered B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Coloplast Ltd. (Denmark), ConvaTec Inc. (UK), Becton, Dickinson and Company (US), Cardinal Health (US), Teleflex Incorporated (US), Wellspect HealthCare (US), and Cook Medical (US), Asid Bonz GmbH (Germany), Degania Silicone Ltd. (Israel), Bactiguard (Sweden), Medical Technologies of Georgia (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Go Medical Industries Pty Ltd. (Australia), Cure Medical, LLC, Amsino International, Inc. (US), Urocare Products, Inc. (US), J and M Urinary Catheters LLC. (US), CompactCath (US), Hunter Urology (England), MANFRED SAUER GMBH (Germany), and Ribbel International Limited (India).

This report categorizes the urinary catheters market into the following segments and subsegments:

By Product

Indwelling Catheters

Intermittent Catheters

External Catheters

By Type

Coated Catheters

Uncoated Catheters

By Usage

Male Urinary Catheters

Female Urinary Catheters

By Application

Urinary Incontinence

General Surgery

Benign Prostatic Hyperplasia

Other Applications (spinal cord injuries, spina bifida, multiple sclerosis, and Parkinson�s disease)

By End-User

Hospitals

Long-Term Care Facilities

Other End Users (emergency clinics and physicians� offices)

By Region

North America US Canada

Europe Germany France UK Italy Spain RoE

Asia Pacific Japan China India Rest of Asia Pacific

Rest of the World

Recent Developments

In 2019, Bactiguard launched BIP Foley TempSensor. This enhanced the urinary catheters product portfolio of Bactiguard.

In 2019, ConvaTec Group acquired Southlake Medical Supplies, Inc. (US). This acquisition helped to strengthen ConvaTec�s distribution of catheter-related supplies in the US.

In 2018, Coloplast acquired IncoCare Gunhild Vieler GmbH (Germany). This acquisition helped strengthen the company�s position in Germany, primarily in home care continence supplies.

Frequently Asked Questions (FAQ):

What is the impact of COVID-19 on the urinary catheters market? The COVID-19 (coronavirus) outbreak has disrupted business and economic activities globally. It is expected to have a short-term impact on the Urinary Catheters market to a certain extent. Who are the key players in the urinary catheters market? The prominent players operating in this market include B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Coloplast Ltd. (Denmark), ConvaTec Inc. (UK), Becton, Dickinson and Company (US), Cardinal Health (US), Teleflex Incorporated (US), Wellspect HealthCare (US), and Cook Medical (US). Which product dominates in the Urinary Catheters market? Indwelling catheters accounted for the largest share of the urinary catheters market in 2019. Growth in this market is largely driven by the cost-efficiency and high availability of indwelling catheters in the market. Which application segment of the global urinary catheters market is expected to witness the highest growth? Urinary Incontinence application is expected to witness the highest growth. What is the market for urinary catheters? The global urinary catheters market is projected to reach USD 2.6 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 5.5% during the forecast period. .

To speak to our analyst for a discussion on the above findings, click Speak to Analyst